| PUBCHEM ID |
53247390
|
| UNII |
78GIB3SHQQ
|
| Preferred Term |
DBPR-110
|
| CAS |
1310694-75-7
|
| INCHIKEY |
FZCLQOXUWMCXCV-XCIZVNRNSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
O=C([C@@H](c1ccccc1)NC(C1CC1)=O)N(CCC1)[C@@H]1c1ncc(-c(cc2)ccc2-c(cc2)ccc2-c2cnc([C@H](CCC3)N3C([C@@H](c3ccccc3)NC(C3CC3)=O)=O)s2)s1
|
| Total Surface Area |
634,58
|
| Relative PSA |
0,22825
|
| TPSA |
181,08
|
| cLogS |
-9,236
|
| MW |
861,101
|
| cLogP |
7,3136
|
| H-Acceptors |
10
|
| H-Donors |
2
|
| Ro5 violations |
2
|
| Druglikeness |
7,7761
|
| DrugScore |
0,139954132195201
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,8972
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Inhibitor
|
| CYP450 3A4 Inhibitor |
Inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,6076
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,5534
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,33
|
| Carcinogenicity (Three-class) |
Non-required
|